personalized neoantigen peptide-based vaccine (Icahn School of Medicine at Mount Sinai)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepersonalized neoantigen peptide-based vaccine (Icahn School of Medicine at Mount Sinai)

Drug Alias Namemutation-derived tumor neoantigen peptide-based vaccine (Mount Sinai)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Antigen > Tumor antigenBiologics > Protein drugs > Recombinant polypeptide +[4]

Mechanisms of ActionT lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesMount Sinai Medical Center/Miami Jewish Home Andhospital For Theed Home Healthency

China Registration ClassN/A

Develop Information

Active CompaniesMount Sinai Medical Center/Miami Jewish Home Andhospital For Theed Home Healthency

Inactive CompaniesN/A

Active IndicationsMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A